BREAKING: 32 y/o Pharma CEO to Roll Back Price Gouge in Response to Nationwide Outrage
https://www.youtube.com/watch?v=YjR0_h1iceQ UPDATE: 32-year-old Martin Shkreli, who recently set off a firestorm of controversy when the pharma CEO hiked the price of Daraprim 5,500 percent, has backed down amid the controversy that had everyone from Hillary Clinton, Bernie Sanders, and just about every news organization denouncing him. Daraprim is a drug that was developed 62 years ago and is used to treat various illnesses and prevent infections in cancer and AIDS patients. Initially, Shkreli was brazen in the face of criticism, claiming that the drug was “still underpriced” even after the titanic price spike. Despite this retraction, the embattled pharma CEO’s...
Read More